SelenBio

antibacterial technology for a wide variety of use cases

Analytics

Raised to Date: $147,972

Aggregate Commitments $
Platform

Netcapital

Start Date

10/03/2019

Close Date

04/28/2020

Min. Goal

$10,000

Max. Goal

$1,070,000

Min. Investment

$4

Security Type

Equity - Common

Funding Type

RegCF

Series

Seed

Pre-Money Valuation

$19,621,196

Rolling Commitments $
Status
Funded
Reporting Date

05/03/2020

Days Remaining
Funded
% of Min. Goal

1,480%

% of Max. Goal

14%

Likelihood of Max
Funded
Avg. Daily Raise

$711

Momentum
Funded
Log in or create a free account today to gain access to KingsCrowd analytics.
Location
Industry

Healthcare & Pharmaceuticals

Tech Sector

Biotech

Distribution Model

B2B

Margin

High

Capital Intensity

High

Business Type

High Growth

SelenBio, a biotechnology company with a post-money valuation of $20.7 million, is raising funds on NetCapital. The company develops an antibacterial technology that prevents the formation of biofilm in dental, medical, industrial, and consumer applications. SelenBio uses a unique selenium-based compound, SELDOX, to keep the applications infection-free. The company was founded by Kenny Gallagher and Karl Doenges. The proceeds of the current crowdfunding round, with a minimum target of $10,000 and a maximum target of $1,070,000, will be used for research & development, operations, completion of current projects, sales & marketing, and compensation for managers. SelenBio is working on multiple projects with excellent traction and has already received the FDA approval for SELDOX.
Summary Profit and Loss Statement
Most Recent Year Prior Year

Revenue

$12,142

$1,039

COGS

$11,785

$871

Tax

$0

$0

 

 

Net Income

$-453,939

$-134,867

Summary Balance Sheet
Most Recent Year Prior Year

Cash

$550,794

$104,479

Accounts Receivable

$153

$213

Total Assets

$1,044,713

$475,538

Short-Term Debt

$0

$0

Long-Term Debt

$0

$0

Total Liabilities

$0

$0

Log in or create a free account today to gain access to KingsCrowd analytics.
Upgrade to gain access
Pay Monthly
Annually (Save 17%)

Starter

$8.33 /month
billed annually
Free portfolio tracking. Limited reports and filters.
Plan Includes:
Everything in Free, plus
Advanced company search ( limited filters)
Founder profiles and exclusive webinars
2 Analyst Reports per month
Get Starter Annual

Pro

$25 /month
billed annually
Unlimited analyst reports and market analytics.
Plan Includes:
Everything in Starter, plus
Full access to all Analyst Reports
Filter on Staff Picks (e.g. Top Deal, Deal to Watch, etc.)
Market Analytics
Get Pro Annual

Merlin

$41.67 /month
billed annually
Full site access including Merlin ratings.
Plan Includes:
Everything in Pro, plus
Search and filter companies by Merlin ratings
Company specific Merlin rating and risk assessment
Get Merlin Annual
Already a member? Log in here.

Ratings

Other Deals

Hidden Company on Platform

Analyst reports are restricted for only Pro and Merlin members. Please upgrade for access.

RegCF
Hidden Company on Platform

Analyst reports are restricted for only Pro and Merlin members. Please upgrade for access.

RegA+
Hidden Company on Platform

Analyst reports are restricted for only Pro and Merlin members. Please upgrade for access.

RegA+
Create your first portfolio
WELCOME TO YOUR OWN INVESTMENTS PORTFOLIO ON KINGSCROWD.

Now you can track all of your startup investments in one place utilizing our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
Add SelenBio on Netcapital
Follow company
Follow SelenBio on Netcapital
Want to learn more about SelenBio?
Join the Pre-IPO Market’s #1 Ratings & Analytics Service FREE for 7 days.
Yes! I want to start my free trial.
Already a member? Log in here.
Invest Now